T1	intervention 0 9	Melatonin
T2	condition 35 55	Radiation Dermatitis
T3	eligibility 506 582	patients who underwent breast-conserving surgery for stage 0-2 breast cancer
T4	intervention-participants 630 632	26
T5	control 643 650	placebo
T6	control-participants 652 654	21
T7	duration 713 720	2 weeks
T8	outcome 1001 1037	grade 1/2 acute radiation dermatitis
T9	intervention-value 1063 1066	59%
T10	control-value 1071 1074	90%
T11	outcome 1154 1164	dermatitis
T12	outcome 1218 1246	maximal radiation dermatitis
T13	intervention-value 1281 1284	15%
